The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of ...

Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing ...

Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause ...

To order this 550+ page report, please visit this link Key Inclusions A detailed review of the overall landscape of companies that are engaged in the ...

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract ...

Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030, covering various important aspects of the industry ...

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house ...

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the ...

To order this detailed 300+ page report, please visit this link Key Inclusions A detailed assessment of the current market landscape, including ...

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer ...